Integrating New Data From IAS 2021

Join 2 leading experts for an interactive Webinar focused on the most clinically relevant data presented at IAS 2021, as well as other key studies that may be significant to the advancement of HIV patient care. Case vignettes will be used to explore integration of findings into everyday patient management.

These in-depth 90-minute CME/CE/CPE-certified Webinars are open to all members. The regional designations listed are to encourage a more localized, small-group format and to better allow that some questions or issues may be addressed by faculty from the specific region.

NOTE: Time zones vary by program region - please confirm the workshop time zone when you register.

August 16, 2021 at 12:00 PM CT – Midwest (MT, WY, CO, ND, SD, NE, KS, MN, IA, MO, WI, IL, MI)

August 17, 2021 at 12:00 PM ET – New York and New Jersey

August 18, 2021 at 12:00 PM ET – North and South Carolina

August 19, 2021 at 12:00 PM ET – New England (MA, NH, CT, RI, ME, VT)

August 20, 2021 at 12:00 PM CT – Southwest US (TX, AZ, NM, OK)

August 23, 2021 at 12:00 PM ET – Florida

August 24, 2021 at 12:00 PM PT – Western US (CA, OR, WA, NV, ID, UT, AK, HI)

August 25, 2021 at 12:00 PM ET – Southeast US

August 26, 2021 at 12:00 PM ET – Maryland/Virginias Region (VA, WV, MD, DC, DE)

August 27, 2021 at 12:00 PM ET  – Pennsylvania, Ohio, Indiana, and Kentucky


The timing and agenda for each webinar is as follows:

  •   Introduction and Program Overview (5 mins)
  •   Key Findings from IAS 2021 (60 minus)
  •   Question and Answer Session (25 mins)


Date / Time
Event Details


Program Director
Joseph J. Eron, Jr., MD

Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Program Director
Princy N. Kumar, MD, FIDSA, MACP

Professor of Medicine and Microbiology
Division of Infectious Diseases and Travel Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC

Jonathan Appelbaum, MD, FACP, AAHIVS

Laurie L. Dozier Jr, MD, Education Director
Professor of Internal Medicine
Department of Clinical Sciences
Florida State University College of Medicine
Tallahassee, Florida

Roger Bedimo, MD, MS, FACP

Professor of Medicine
Division of Infectious Diseases
University of Texas Southwestern Medical Center
Section Chief
Division of Infectious Diseases
Department of Internal Medicine
VA North Texas Health Care System
Dallas, Texas

Michelle S. Cespedes, MD, MS

Associate Professor of Medicine Division of Infectious Diseases
Icahn School of Medicine at Mount Sinai
New York City, NY

Eric S. Daar, MD

Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Monica Gandhi, MD, MPH

Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
University of California, San Francisco
Medical Director
Ward 86 HIV Clinic
San Francisco General Hospital
San Francisco, California

Jason Halperin, MD, MPH

Assistant Professor of Medicine
Department of Infectious Diseases
Tulane University
Infectious Disease Physician
New Orleans, Louisiana

W. David Hardy, MD

Scientific and Medical Consultant
Adjunct Professor of Medicine

Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland

Daniel R. Kuritzkes, MD

Chief, Division of Infectious Diseases
Brigham and Women's Hospital
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Mary Montgomery, MD

Instructor of Medicine
Harvard Medical School
Associate Physician
Division of Infectious Disease
Department of Medicine
Brigham and Women's Hospital
Boston, Massachusetts

Paul E. Sax, MD

Clinical Director
HIV Program and Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Renslow Sherer, MD

Director, International HIV Training Center
Professor of Medicine
University of Chicago
Chicago, Illinois

William R. Short, Other

Shobha Swaminathan, MD

Associate Professor
Division of Infectious Diseases
Department of Medicine
Rutgers New Jersey Medical School
Newark, New Jersey

Alan J. Taege, MD, FIDSA

Assistant Professor of Medicine
Department of Medicine
Cleveland Clinic Lerner College of Medicine
Staff Physician
Department of Infectious Disease
Cleveland Clinic
Cleveland, Ohio

Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Timothy J. Wilkin, MD, MPH

Professor of Medicine
Division of Infectious Diseases
Weill Cornell Medical College
New York, New York

David A. Wohl, MD

Professor of Medicine
School of Medicine
Site Leader,  AIDS Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Director, North Carolina AIDS Training and Education Center
Chapel Hill, North Carolina
Co-Director, HIV Services
North Carolina Department of Correction
Raleigh, North Carolina

Goal Statement
The goal of this activity is to improve learners’ competence in providing optimal care for HIV-infected patients through the appropriate use of contemporary ARV regimens.

Target Audience
This program is intended for physicians, registered nurses, pharmacists, and other healthcare professionals who provide care for patients with HIV infection.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Appropriately counsel patients regarding data from clinical trials evaluating the use of antiretroviral agents to prevent HIV infection
  • Incorporate the results of recent clinical studies when utilizing antiretroviral agents for individualized management of HIV infection
  • Provide insightful counsel to patients and colleagues regarding studies of investigational antiretroviral agents and strategies in advanced stages of development


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. UAN: JA4008176-0000-21-120-L02-P

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.